Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 4.35% vs -1.05% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 3.25% vs 399.62% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 1.25% vs 21.05% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is -11.57% vs -12.87% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
Compare Quarterly Results Of Symbiotec Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 4.35% vs -1.05% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 8.96%
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 3.25% vs 399.62% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 13.94%
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 1.25% vs 21.05% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -0.89%
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -11.57% vs -12.87% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -21.61%
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025